The Economist Intelligence Unit (EIU) forecasts that the five MENA markets covered in this collection will represent a combined GDP of US$ 2.5 trillion in 2016, led by Turkey and Saudi Arabia. Economic development is changing the epidemiological health profile in the region, with the increasing prevalence of communicable diseases.
Using a combination of theory and practical case studies, the course will allow delegates to develop the knowledge needed to successfully navigate the pharmaceutical market in MENA. The course leader will cover specific regulatory requirements, new developments or particular questions of interest within the region and countries to be discussed will include:
Performance and Knowledge Objectives
Book before the 8th September: £1395 + 20% VAT = £1674
Book after the 8th September: £1495 + 20% VAT = £1794
Sign in to add slides, notes or videos to this session